ATIP vs. KALA, AXDX, GLYC, BIVI, APTO, GLTO, NNVC, FLGC, CERO, and MHUA
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include KALA BIO (KALA), Accelerate Diagnostics (AXDX), GlycoMimetics (GLYC), BioVie (BIVI), Aptose Biosciences (APTO), Galecto (GLTO), NanoViricides (NNVC), Flora Growth (FLGC), CERo Therapeutics (CERO), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical" sector.
ATI Physical Therapy (NYSE:ATIP) and KALA BIO (NASDAQ:KALA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends.
72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 24.6% of KALA BIO shares are held by institutional investors. 0.9% of ATI Physical Therapy shares are held by company insiders. Comparatively, 13.4% of KALA BIO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
KALA BIO has a consensus target price of $18.00, suggesting a potential upside of 156.78%. Given KALA BIO's higher possible upside, analysts plainly believe KALA BIO is more favorable than ATI Physical Therapy.
KALA BIO has a net margin of 0.00% compared to ATI Physical Therapy's net margin of -8.15%. ATI Physical Therapy's return on equity of 0.00% beat KALA BIO's return on equity.
In the previous week, ATI Physical Therapy had 2 more articles in the media than KALA BIO. MarketBeat recorded 4 mentions for ATI Physical Therapy and 2 mentions for KALA BIO. KALA BIO's average media sentiment score of 0.30 beat ATI Physical Therapy's score of -0.54 indicating that KALA BIO is being referred to more favorably in the news media.
KALA BIO has lower revenue, but higher earnings than ATI Physical Therapy. KALA BIO is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
KALA BIO received 282 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 66.59% of users gave KALA BIO an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
ATI Physical Therapy has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500. Comparatively, KALA BIO has a beta of -1.75, meaning that its share price is 275% less volatile than the S&P 500.
Summary
KALA BIO beats ATI Physical Therapy on 10 of the 17 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
